FEMY FEMASYS INC

Nasdaq femasys.com


$ 0.82 $ -0.10 (-10.67 %)    

Thursday, 13-Nov-2025 19:01:45 EST
QQQ $ 608.59 $ -9.26 (-1.5 %)
DIA $ 475.50 $ -6.59 (-1.37 %)
SPY $ 672.57 $ -8.41 (-1.24 %)
TLT $ 89.38 $ -0.42 (-0.46 %)
GLD $ 384.40 $ -4.31 (-1.11 %)
$ 0.8266
$ 0.93
$ 0.80 x 5,746
$ 0.89 x 4,825
-- - --
$ 0.31 - $ 1.80
3,918,846
na
nm
$ 0.38
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 femasys-announces-start-of-post-market-surveillance-clinical-study-for-its-ce-marked-fembloc-permanent-birth-control-conducted-under-eu-medical-device-regulation-in-collaboration-with-regional-medical-experts

Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more acces...

Core News & Articles

- Reuters

Core News & Articles

https://www.youtube.com/watch?v=xagrobF4q1k 

Core News & Articles

https://www.youtube.com/watch?v=xagrobF4q1k 

Core News & Articles

https://www.nytimes.com/2025/10/16/us/politics/trump-ivf-fertility.html

 femasys-partners-with-kebomed-to-commercialize-fembloc-permanent-birth-control-in-france-and-benelux-region

Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more acce...

 femasys-partners-with-medical-electronic-systems-to-provide-advanced-sperm-analysis-technology

Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more acces...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION